From: |
|
Alison Bunce - Medicines and Healthcare Products Regulatory Agency
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Trusts (England) - Medical Director
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
|
|
|
- Clinical Commissioning Groups
- NHS Foundation Trusts (England) - Chief Executive
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Director of Public Health
- NHS Trusts (England) - Chief Executive
|
Title: |
|
DRUG ALERT CLASS 4, FOR INFORMATION, ACCORD HEALTHCARE LIMITED, AMOXICILLIN 500MG CAPSULES BP
|
Broadcast content: |
|
Issue of a 'Caution in Use' notification regarding the late implementation of the updated Patient Information Leaflet (PIL) for certain batches of the above product.
NB It is not necessary to forward this Drug Alert to non-dispensing GPs.
Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts |
|
Cascade to: |
|
- #COMMUNITYPHARMACISTS#
- #DISPENSING GP#
|